CENTER OF MOLECULAR IMMUNOLOGY

Trials shown by sponsor

Public title	Date of Registration	State
VSSPs in renal carcinoma.	21/06/2023	Registered
VSSP in renal cell carcinoma	08/04/2021	Registered
VSSP in metastasic renal cell carcinoma	08/08/2018	Registered
Vaxira as adjuvant treatment for non-small cell lung cancer	15/12/2015	Registered outdated
Vaccine HER1 / VSSP for prostate cancer, head and neck carcinoma and advanced colon cancer . Phase I	03/11/2017	Registered
Use of h-R3 monoclonal antibody and radiotherapy to treat patients with advanced epithelial head and neck tumors.	2010-12-17	Registered
Treatment of SARS CoV-2 pneumonia with the anti-CD6 monoclonal antibody itolizumab	12/05/2020	Registered outdated
Toxicological evaluation of the humanized Anti-CD6 MAb T1h in Rheumatoid Arthritis Patients	2010-12-24	Registered
T1h in severe psoriasis-expanded access program (PUCE)	2012-07-20	Registered
Study of the mechanism of action of Nimotuzumab in patients with head and neck tumors	17/02/2017	Registered
Safety and efficacy of VAXIRA® in advanced NSCLC patients not progressing after first line chemotherapy. Phase III.	01/10/2020	Registered outdated
Safety and efficacy of CIMAvax®-EGF in combination with tyrosine kinase inhibitors in patients with advanced stage Non-Small Cell Lung Cancer and EGFR mutations	22/05/2021	Registered outdated
RituxCIM in relapsed or refractory indolent B-cell non-Hodgkin lymphoma	05/11/2013	Registered outdated
Racotumomab-alum for recurrent platimun-sensitive epithelial ovarian cancer	08/07/2015	Registered
Racotumomab-alum cancer vaccine for solid tumors in pediatric patients	15/12/2015	Registered
Racotumomab,Nimotuzumab or Docetaxel in the treatment of the advanced non-small cell lung cancer.	26/05/2014	Registered
Racotumomab vaccine- Lung Cancer- Adults-predictors of response - Exploratory	09/07/2018	Registered
Preventive use of CIMAvax-EGF in patients at high risk of lung cancer. PREVAX	21/05/2021	Registered outdated
Predictor of response with CIMAvax EGF© in NSCLC Phase III	29/01/2016	Registered
Post EUA study of Itolizumab in COVID-19	21/03/2022	Registered outdated

Registered Trials

Registration process

CENTER OF MOLECULAR IMMUNOLOGY

About the RPCEC

Useful resources